Sort releases Relevance Date of release
BGI Installs Roche GS FLX+ System to Enhance Long Read Sequencing Capabilities for Genome and Transcriptome Research
, Biotechnology, Roche Diagnostics GmbH
BGI, one of the world's largest genomics organizations, announced today that a new Roche GS FLX+ System has been successfully installed at its facility in Shenzhen,...
BGI installiert GS FLX+ System von Roche zur Erweiterung des eigenen Sequenzierungsangebots mit langen Leseweiten für die Genom- und Transkriptomforschung
, Biotechnology, Roche Diagnostics GmbH
BGI, eines der größten Genom-Unternehmen der Welt, gab heute die Installation eines neuen GS FLX+ Systems von Roche am Standort in Shenzhen (China) bekannt. Hiermit...
Roche NimbleGen and BGI develop advanced MHC region capture technology for human disease and biomedical research
, Research / Development, Roche Diagnostics GmbH
Roche NimbleGen, Inc. and BGI, the world's largest genomic organization, announced that they have developed a Major Histocompatibility Complex (MHC) region capture...
Roche NimbleGen stellt neues Multiplex-Verfahren für die Schritte vor der Sequenzanreicherung zur Sequenzierung vor
, Research / Development, Roche Diagnostics GmbH
Mit sinkenden Kosten und steigendem Durchsatz von Sequenzierungen benötigen Forscher ein leistungsfähiges und wirtschaftliches Probenvorbereitungssystem für die...
Roche NimbleGen Announces New Pre-capture Multiplexing for Target Enrichment Technology in Sequencing
, Research / Development, Roche Diagnostics GmbH
With the decreasing cost and increasing throughput of sequencing, researchers require a highperformance, cost-effective sample preparation pipeline for targeted...
Roche Researchers Sequence Complete Genome of Cynomolgus Monkey and Develop Novel Gene Expression Microarray for Drug Safety Assessment
, Biotechnology, Roche Diagnostics GmbH
A team of researchers from Roche (SIX: RO, ROG; OTCQX: RHHBY), including scientists from Roche Pharma Research and Early Development and Roche NimbleGen, reported...
Erasmus Medical Center der Universität Rotterdam setzt automatisches Genanreicherungssystem von Roche NimbleGen und Caliper Life Sciences für eine Exomstudie mit 3000 Proben ein
, Research / Development, Roche Diagnostics GmbH
Das Genetiklabor des Instituts für Innere Medizin des Erasmus Medical Center der Universität Rotterdam (Niederlande) wird das automatische Genanreicherungssystem...
Erasmus University Medical Centre in Rotterdam Adopts Automated Target Enrichment Solution from Roche NimbleGen and Caliper Life Sciences for 3,000 Sample Exome Study
, Research / Development, Roche Diagnostics GmbH
The Genetic Laboratory of the Department of Internal Medicine at Erasmus University Medical Centre in Rotterdam has adopted the combined automated target enrichment...
The Roy J. Carver Center for Genomics (CCG) Achieves Certified Service Provider status for Roche NimbleGen microarrays
, Research / Development, Roche Diagnostics GmbH
In May 2011, The University of Iowa, Roy J. Carver Center for Genomics (CCG), entered into an agreement with Roche NimbleGen to provide microarray services through...
Roche and PerkinElmer Enter into New Agreement for Distribution of NimbleGen CGX Cytogenetics Array Workflow
, Company-internal, Roche Diagnostics GmbH
Roche (SIX: RO, ROG; OTCQX: RHHBY) and PerkinElmer (NYSE: PKI) today announced a new supply agreement for distribution of the NimbleGen CGX microarray workflow,...
Roche NimbleGen und Caliper entwickeln gemeinsam ein automatisches Genanreicherungssystem für die Next-Generation-Sequenzierung
, Biotechnology, Roche Diagnostics GmbH
Roche NimbleGen und Caliper Life Sciences, Inc., haben eine Co-Marketing-Vereinbarung getroffen, nach der sie auf Basis der NimbleGen SeqCap EZ Libraries gemeinsam...
Roche NimbleGen and Caliper Collaborate to Offer Automated Target Enrichment Pipeline Solution for Next-Generation Sequencing
, Biotechnology, Roche Diagnostics GmbH
Roche (SIX: RO, ROG; OTCQX: RHHBY) and Caliper Life Sciences, Inc. (NASDAQ: CALP) today announced a co-marketing agreement for the development and optimization of...
Agreement with Roche gives UCLA Stem Cell and Cancer Researchers Early Access to Leading-edge Technologies for the Advancement of Medical Research
, Medical Technology, Roche Diagnostics GmbH
An agreement between UCLA and Roche (SIX: RO, ROG; OTCQX: RHHBY) will provide stem cell and cancer researchers with leading-edge technologies that will drive research...
Vereinbarung zwischen Roche und UCLA ermöglicht Stammzell- und Krebsforschern frühen Zugang zu modernsten Technologien für die medizinische Forschung
, Cooperations / Mergers, Roche Diagnostics GmbH
Roche (SIX: RO, ROG; OTCQX: RHHBY) und die University of California in Los Angeles (UCLA) haben vereinbart, dass UCLA-Wissenschaftler aus den Bereichen Stammzellforschung...
BaseClear BV Certified to Provide NimbleGen Sequence Capture Services in the Netherlands
, Company-internal, Roche Diagnostics GmbH
Roche NimbleGen, a Roche (SIX: RO, ROG; OTCQX: RHHBY) Company announced today that the Netherlands-based genomic service provider BaseClear BV has officially joined...
This search as:
Similar keywords
Categories
- Biotechnology (59)
- Research / Development (33)
- Company-internal (13)
- Cooperations / Mergers (12)
- Medical Technology (4)
All categories



